Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.756 USD | +0.81% | +0.01% | -32.43% |
May. 20 | Bolt Biotherapeutics, Inc. Announces Management Changes | CI |
May. 20 | Bolt Biotherapeutics, Inc. Announces Chief Executive Officer Changes | CI |
Financials (USD)
Sales 2024 * | 8.5M | Sales 2025 * | 19.94M | Capitalization | 28.59M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -47M | EV / Sales 2024 * | -19.6 x |
Net cash position 2024 * | 196M | Net cash position 2025 * | 244M | EV / Sales 2025 * | -10.8 x |
P/E ratio 2024 * |
-0.6
x | P/E ratio 2025 * |
-0.79
x | Employees | 100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.53% |
1 day | +0.81% | ||
1 week | +0.01% | ||
Current month | +0.01% | ||
1 month | -29.93% | ||
3 months | -39.46% | ||
6 months | -18.62% | ||
Current year | -32.43% |
Managers | Title | Age | Since |
---|---|---|---|
William Quinn
CEO | Chief Executive Officer | 53 | 20-04-30 |
John Tomaro
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Priti Hegde
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Miller
BRD | Director/Board Member | 73 | 17-06-30 |
Mahendra Shah
BRD | Director/Board Member | 79 | 16-08-31 |
James Healy
BRD | Director/Board Member | 59 | 20-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.75 | +0.01% | 166 835 |
24-06-06 | 0.7499 | -0.41% | 212,134 |
24-06-05 | 0.753 | -0.63% | 102,530 |
24-06-04 | 0.7578 | -1.01% | 133,324 |
24-06-03 | 0.7655 | +1.16% | 243,800 |
Delayed Quote Nasdaq, June 07, 2024 at 03:39 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.43% | 28.59M | |
+19.08% | 125B | |
+14.32% | 108B | |
-4.84% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.55% | 13.39B | |
+28.16% | 11.1B |
- Stock Market
- Equities
- BOLT Stock